Nucynta ER is approved to treat neuropathic pain associated with diabetic peripheral neuropathy in adult patients. It is the only opioid approved by the FDA for DPN-associated neuropathic pain.
More Articles on Pain Management:
10 Pain Management Physicians on the Move
ASIPP Releases Guidelines on Opioid Prescriptions for Non-Cancer Pain Patients
Kansas University Hospital Addition Includes Pain Management
Janssen Pharmaceuticals Receives FDA Clearance for Nucynta ER
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, has received approval from the Food and Drug Administration for a new supplemental drug for an opioid analgesic to treat pain related to diabetes.
From repetitive to real-time: AI that lightens the back-office load
Recommended Live Webinar on Jan 22, 2026 12:00 PM - 1:00 PM CST